Two Sigma Securities’s Coherus Oncology CHRS Stock Holding History

Two Sigma Securities’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.1K	Buy	+10,043	New	+$16.4K	﹤0.01%	1528
2026 Q1	–	Sell	-14,587	Closed	-$20.7K	–	1718
2025 Q4	$20.7K	Sell	14,587 -119	-0.8%	-$173	﹤0.01%	1175
2025 Q3	$24.1K	Buy	+14,706	New	+$16.4K	﹤0.01%	1105
2024 Q4	–	Sell	-21,594	Closed	-$22.5K	–	1880
2024 Q3	$22.5K	Buy	+21,594	New	+$29.6K	﹤0.01%	2481
2023 Q4	–	Sell	-13,762	Closed	-$51.5K	–	3083
2023 Q3	$51.5K	Buy	+13,762	New	+$63.6K	﹤0.01%	2472

Other funds holding CHRS

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Two Sigma Securities's CHRS Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Coherus Oncology (CHRS) in Q2 2026: 10,043 shares worth $14.1K. The stake represents ﹤0.01% of the portfolio and ranks #1528 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CHRS as recently as Q4 2025.

Two Sigma Securities first reported a position in CHRS in Q3 2023 and has held it in 5 quarters since. The position peaked at $51.5K in Q3 2023. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

Two Sigma Securities held 10,043 shares of Coherus Oncology worth $14.1K as of Q2 2026.
Coherus Oncology was a new Two Sigma Securities position in Q2 2026.
Coherus Oncology made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1528 holding.
Two Sigma Securities first reported a position in Coherus Oncology in Q3 2023 and has held it in 5 quarters since.
Two Sigma Securities's Coherus Oncology position peaked at $51.5K in Q3 2023.
146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.